Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 2, 2004, Pages 298-300

  Sporer, B ^b   Koedel, U ^b   Paul, R ^b   Eberle, J ^b   Arendt, G ^a   Pfister, H W ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VASCULOTROPIN; VASCULOTROPIN A;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD; BLOOD SAMPLING; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REDUCTION; RETROVIRUS; STATISTICAL SIGNIFICANCE; TENSION HEADACHE; VIROLOGY; VIRUS LOAD; VIRUS MENINGITIS;

AIDS DEMENTIA COMPLEX; HIV SEROPOSITIVITY; HUMANS; MENINGITIS, VIRAL; TENSION-TYPE HEADACHE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0842309185     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.016287     Document Type: Article

References (12)

1. Ferrara N. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 2000;11:617-24.
2. Esser S, Wolburg K, Wolburg H, et al. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998;140:947-59.
3. Mühlhauser J, Merrill MJ, Pili R, et al. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 1995;77:1077-86.
4. Paul R, Zhang ZG, Eliceiri BP, et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001;7:222-7.
5. Sporer B, Paul R, Koedel U, et al. Detection of matrixmetalloproteinase- 9 in the cerebrospinal fluid of HIV-infected patients. J Infect Dis 1998;178:854-7.
6. Sporer B, Koedel U, Paul R, et al. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 2000;102:125-30.
7. Heidenreich F, Arendt G, Jander S, et al. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases. J Neuroimmunol 1994;52:117-26.
8. Persidsky Y, Limoges J, McComb R, et al. Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol 1996;149:1027-53.
9. Mercie P, Devianne I, Viallard JF, et al. Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma. Microvasc Res 1999;57:208-10.
10. Ascherl G, Hohenadl C, Schatz O, et al. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy. Blood 1999;93:4232-41.
11. Glass JD, Fedor H, Wesselingh SL, et al. Immuncytochemical quantitation of human immunodeficiency virus in the brain: correlation with dementia. Ann Neurol 1995;38:755.
12. Carmeliet P, Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin Cell Dev Biol 2002;13:39-53.